Our study in Jordan is able to move another step forward now that we have reached an agreement with a Jordanian insurance agency. Now that the study is insured we can submit the protocol to the Jordanian institutional review board (IRB). We have also reached an agreement with Principal Investigator Nasser Shuriquie, M.D. that the subjects enrolled in the study will be treatment resistant. This means that subjects will have to have previously attempted talk and drug therapy to treat their PTSD without success.